Thyroid, Gonadal and Adrenal Dysfunction in Kidney Transplant Recipients: A Review for the Clinician

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2023-05, Vol.13 (6), p.920
• Main Authors: Bilha, Stefana Catalina, Hogas, Simona, Hogas, Mihai, Marcu, Stefan, Leustean, Letitia, Ungureanu, Maria-Christina, Branisteanu, Dumitru D, Preda, Cristina
• Format: Article
• Language: English
• Subjects: Adrenal glands; Bone diseases; Care and treatment; chronic kidney disease; Chronic kidney failure; Cohort analysis; Complications and side effects; cortisol; Endocrine System Diseases; Female; Glucocorticoids; Gonads; Health aspects; Hemodialysis; Hemodynamics; Hormones; Humans; Hyperthyroidism; Hypogonadism; hypothalamic-pituitary–adrenal axis; Hypothalamo-Hypophyseal System; Hypothalamus; Hypothyroidism; Kidney diseases; Kidney transplantation; Kidney Transplantation - adverse effects; Kidney transplants; Kidneys; Malnutrition; Metabolic syndrome; Metabolism; Minerals; Mortality; Observational studies; Organ transplant recipients; Patients; Peritoneal dialysis; Physiological aspects; Pituitary; Pituitary-Adrenal System; Proteins; Quality of Life; Renal Insufficiency, Chronic; Review; sex hormones; Testosterone; Thyroid; Thyroid Gland; thyroid hormones; Transplantation; Triiodothyronine
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom13060920

While chronic kidney disease-associated mineral and bone disorders (CKD-MBD) prevail in the endocrinological assessment of CKD patients, other endocrine abnormalities are usually overlooked. CKD is associated with significant thyroid, adrenal and gonadal dysfunction, while persistent and de novo endocrinological abnormalities are frequent among kidney transplant recipients (KTR). Low T3 levels prior to transplantation may help identify those at risk for delayed graft function and are often found in KTR. Thyroid surveillance after kidney transplantation should be considered due to structural anomalies that may occur. Despite the rapid recovery of gonadal hormonal secretion after renal transplantation, fertility is not completely restored. Testosterone may improve anemia and general symptoms in KTR with persistent hypogonadism. Female KTR may still experience abnormal uterine bleeding, for which estroprogestative administration may be beneficial. Glucocorticoid administration suppresses the hypothalamic-pituitary-adrenal axis in KTR, leading to metabolic syndrome. Patients should be informed about signs and symptoms of hypoadrenalism that may occur after glucocorticoid withdrawal, prompting adrenal function assessment. Clinicians should be more aware of the endocrine abnormalities experienced by their KTR patients, as these may significantly impact the quality of life. In clinical practice, awareness of the specific endocrine dysfunctions experienced by KTR patients ensures the correct management of these complications in a multidisciplinary team, while avoiding unnecessary treatment.